Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 2601-2620 of 3,347 trials

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

NCT00522548

Myfortic (enteric-coated mycophenolate sodium) has been shown to have similar effectiveness to CellCept (mycophenolate mofetil) in preventing rejection in kidney transplant recipients. However, enteric coated mycophenolate sodium has been thought to possibly be associated with fewer gastrointestinal side effects. Mycophenolate mofetil and enteric coated mycophenolate sodium pharmacokinetics (how the drug is absorbed and broken down) have not been well-studied in African American kidney transplant recipients. The investigators are interested in studying enteric coated mycophenolate sodium and mycophenolate mofetil pharmacokinetics and gastrointestinal side effects in African American kidney transplant recipients.

Transplants and Implants

University of Pennsylvania37 participantsStarted Mar 2007

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

NCT00435942

The purpose of this study is to evaluate the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1-year. Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent surgical repair. Long term follow-up is conducted through 5 years.

Thoracic Aortic Aneurysmsand Penetrating Atherosclerotic Ulcers

Bolton Medical180 participantsStarted Jan 2007

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Francisco, California, United States +24 more locations

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Rheumatoid Arthritis Trials in Other Cities

Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Treatment of Smoking Among Individuals With PTSD

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Medication Adherence in Children Who Had a Liver Transplant

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Safety Escalating Repeat IV, in Stroke Patients

Other Conditions in Philadelphia